INTEST CORP
For the period ended Jun 17, 2026. Filed Apr 28, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 17, 2026 · Filed Apr 28, 2026
Contents
Proxy Statement Summary
804 East Gate Drive, Suite 200
Mt. Laurel, New Jersey 08054
PROXY STATEMENT SUMMARY
To assist you in reviewing the proposals to be considered and voted upon at our Annual Meeting, we have summarized information contained elsewhere in this proxy statement or in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Annual Report”). This summary does not contain all of the information you should consider about InTest Corporation (“InTest”, the “Company”, “we”, “us” or “our”) and the proposals being submitted to stockholders at the Annual Meeting. We encourage you to read the entire proxy statement and Annual Report carefully before voting.
The Annual Meeting
| Date & Time | Location | Record Date |
|---|---|---|
| Wednesday, June 17, 2026 | Online via: | April 20, 2026 |
| 11:00 a.m. Eastern Time | www.proxydocs.com/INTT |
Because the meeting is being held virtually, you will not be able to attend the Annual Meeting in person but are invited to join us in the virtual Annual Meeting. In order to attend virtually, you must register in advance atwww.proxydocs.com/INTT before 5:00 p.m. Eastern Time on June 16, 2026. Upon completing your registration, you will receive further instructions via email, including your unique link that will allow you to access the Annual Meeting. If you wish to attend virtually as guest, you may attend in listen-only mode by clicking on “I am a guest” after linking on the meeting site atwww.proxydocs.com/INTT and entering the information requested.
Meeting Agenda and Voting Matters
| Item | Proposal | Board of Directors VoteRecommendation | Page Reference (for more information) |
|---|---|---|---|
| 1. | Election of the five director nominees named in this proxy statement | FOR each nominee | 30 |
| 2. | Approval of Amendment No.1 to the InTest Corporation 2023 Stock Incentive Plan | FOR | 30 |
| 3. | Ratification of the appointment of RSM US LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026 | FOR | 38 |
| 4. | Approval, on an advisory basis, of the compensation of our named executive officers | FOR | 39 |
Nominees to Our Board of Directors (the “Board”)
| Name | Age | Recent Professional Experience | Independent | Board Committees |
|---|---|---|---|---|
| Steven J. Abrams, Esq. | 58 | Partner and Global Co-Head of Life Sciences and Health Care, Hogan Lovells US LLP | ü | AC, CC, NCGC*** |
| Jeffrey A. Beck** | 63 | Former CEO, Soft Robotics Inc. | ü | AC, CC*** |
| Joseph W. Dews IV* | 59 | Managing Director, Craig-Hallum | ü | CC, NCGC |
| Karl E. Johnsen | 57 | CFO, Intelerad Medical Systems Inc. | ü | AC***†, NCGC† |
| Richard Rogoff | 59 | President and Chief Executive Officer of InTest | — | — |
| * | Chair of the Board | AC: | Audit Committee |
|---|---|---|---|
| ** | Vice Chair of the Board | CC: | Compensation Committee |
| *** | Committee Chair | NCGC: | Nominating and Corporate Governance Committee |
| † | Mr. Johnsen is not currently a director. If elected, the Board anticipates appointing him as Audit Committee Chair and as a member of the Nominating and Corporate Governance Committee. | ||
InTest Corporation |2026 Proxy Statement -1
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.